{"DataElement":{"publicId":"2831122","version":"1","preferredName":"Tumor Histologic Subtype Type","preferredDefinition":"Text term to represent the category for a neoplasm's histologic subtype.","longName":"TUMO_HIST_SUBTP_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2830866","version":"1","preferredName":"Tumor Histologic Subtype","preferredDefinition":"information related to a tumor's histologic subtype.","longName":"TUM_HIST_SUBTP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207639","version":"1","preferredName":"Histologic Subtype","preferredDefinition":"Of or relating to histology.:Subtype; a group forming a type within a larger type.","longName":"C25526:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2AE5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7CA2-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2831116","version":"1","preferredName":"Neoplasm Histologic Subtype Type","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)_Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A group forming a type within a larger type._Type; a subdivision of a particular kind of thing.","longName":"TUMO_HIST_SUBTP_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Papillary renal cell carcinoma","valueDescription":"Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"61F598EF-7CE6-BDE9-E040-BB89AD43552F","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous Cell Carcinoma","ValueMeaning":{"publicId":"2567412","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"2567412","preferredDefinition":"A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D461-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-10","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"61F598EF-7CFB-BDE9-E040-BB89AD43552F","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"61F598EF-7D1E-BDE9-E040-BB89AD43552F","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","deletedIndicator":"No"},{"value":"Cystadenocarcinoma","valueDescription":"Cystadenocarcinoma","ValueMeaning":{"publicId":"2831119","version":"1","preferredName":"Cystadenocarcinoma","longName":"2831119","preferredDefinition":"A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cystadenocarcinoma","conceptCode":"C2971","definition":"A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D2C-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"61F598EF-7D45-BDE9-E040-BB89AD43552F","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","deletedIndicator":"No"},{"value":"Glioblastoma multiforme","valueDescription":"Glioblastoma multiforme","ValueMeaning":{"publicId":"2831120","version":"1","preferredName":"Glioblastoma multiforme","longName":"2831120","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV).  It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D4F-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"61F598EF-7D68-BDE9-E040-BB89AD43552F","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","deletedIndicator":"No"},{"value":"Mixed Histology","valueDescription":"Mixed Histology","ValueMeaning":{"publicId":"3084098","version":"1","preferredName":"Mixed Histology","longName":"3084098","preferredDefinition":"An invasive breast carcinoma containing both ductal and lobular carcinomatous components.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mixed Carcinoma","conceptCode":"C40347","definition":"An invasive breast carcinoma characterized by the presence of more than one malignant epithelial histologic pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8638268D-A4B9-7AFE-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8638268D-A4D2-7AFE-E040-BB89AD43791D","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"ONEDATA","dateModified":"2010-05-10","deletedIndicator":"No"},{"value":"Infiltrating Lobular","valueDescription":"Infiltrating Lobular","ValueMeaning":{"publicId":"3084100","version":"1","preferredName":"Infiltrating Lobular","longName":"3084100","preferredDefinition":"The diffusion or accumulation in a tissue or cells of substances not normal to it or in amounts above normal.: Lobular; of or relating to or resembling a lobule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infiltration","conceptCode":"C25754","definition":"The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lobular","conceptCode":"C25557","definition":"Of or relating to or resembling a lobule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8638268D-A502-7AFE-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8638268D-A51B-7AFE-E040-BB89AD43791D","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"ONEDATA","dateModified":"2010-05-10","deletedIndicator":"No"},{"value":"Infiltrating Carcinoma NOS","valueDescription":"Infiltrating Carcinoma NOS (Not Otherwise Specified)","ValueMeaning":{"publicId":"3084101","version":"1","preferredName":"Infiltrating Carcinoma NOS (Not Otherwise Specified)","longName":"3084101","preferredDefinition":"The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI): A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infiltration","conceptCode":"C25754","definition":"The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8638268D-A543-7AFE-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/05/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8638268D-A55C-7AFE-E040-BB89AD43791D","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"ONEDATA","dateModified":"2010-05-10","deletedIndicator":"No"},{"value":"Muscle invasive urothelial carcinoma","valueDescription":"Muscle Invasive Urothelial Carcinoma","ValueMeaning":{"publicId":"3130365","version":"1","preferredName":"Muscle Invasive Urothelial Carcinoma","longName":"3130365","preferredDefinition":"Muscle; one of the contractile organs of the body.: Marked by a tendency to spread especially into healthy tissue.: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle","conceptCode":"C13056","definition":"One of the contractile organs of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E285AD7-01B8-F79F-E040-BB89AD430515","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E285AD7-01D1-F79F-E040-BB89AD430515","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Serous Cystadenocarcinoma","valueDescription":"Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"3438800","version":"1","preferredName":"Serous Cystadenocarcinoma","longName":"3438800","preferredDefinition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Cystadenocarcinoma","conceptCode":"C3778","definition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE0A5415-E62F-6FDD-E040-BB89AD4348BB","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE0A5415-E647-6FDD-E040-BB89AD4348BB","beginDate":"2012-04-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","deletedIndicator":"No"},{"value":"Poorly differentiated/ pleomorphic/ epithelioid leiomyosarcoma","valueDescription":"Poorly Differentiated Pleomorphic Epithelioid Leiomyosarcoma","ValueMeaning":{"publicId":"3521458","version":"1","preferredName":"Poorly Differentiated Pleomorphic Epithelioid Leiomyosarcoma","longName":"3521458","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: Occurring in various distinct forms.  In terms of cells, having variation in the size and shape of cells or their nuclei.: A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pleomorphic","conceptCode":"C28109","definition":"Occurring in various distinct forms.  In terms of cells, having variation in the size and shape of cells or their nuclei.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epithelioid Leiomyosarcoma","conceptCode":"C3700","definition":"A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4797330-5180-D51E-E040-BB89AD4357AD","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4797330-5199-D51E-E040-BB89AD4357AD","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"ONEDATA","dateModified":"2012-07-10","deletedIndicator":"No"},{"value":"Conventional leiomyosarcoma","valueDescription":"Conventional Leiomyosarcoma","ValueMeaning":{"publicId":"3521460","version":"1","preferredName":"Conventional Leiomyosarcoma","longName":"3521460","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conventional Leiomyosarcoma","conceptCode":"C9428","definition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4797330-51A6-D51E-E040-BB89AD4357AD","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4797330-51BF-D51E-E040-BB89AD4357AD","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"ONEDATA","dateModified":"2012-07-10","deletedIndicator":"No"},{"value":"Well-differentiated leiomyosarcoma (resembling leiomyoma)","valueDescription":"Well Differentiated Leiomyosarcoma","ValueMeaning":{"publicId":"3521461","version":"1","preferredName":"Well Differentiated Leiomyosarcoma","longName":"3521461","preferredDefinition":"Definition not available.: An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4797330-51CC-D51E-E040-BB89AD4357AD","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C47FC0DE-5331-0CAF-E040-BB89AD43583B","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"ONEDATA","dateModified":"2012-07-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2831115","version":"1","preferredName":"Neoplasm Histologic Subtype Type","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:Of or relating to histology.:Subtype; a group forming a type within a larger type.:Type; a subdivision of a particular kind of thing.","longName":"C3262:C25526:C25696:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7CB8-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"ONEDATA","dateModified":"2009-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7CC9-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"COOPERM","dateModified":"2012-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"}]}],"AlternateNames":[{"name":"Leiomyosarcoma Histologic Subtype","type":"TCGA_Name","context":"NCIP"},{"name":"leiomyosarcoma_histologic_subtype","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histological subtype","type":"Preferred Question Text","description":"Histological subtype","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"pT2 or above","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D72-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"TSESU","dateModified":"2018-07-10","changeDescription":"Approved by M. Hatfield, Clinical Outreach Manager for TCGA, on 2/2/2009. Permissible values added per Tara Lichtenberg 5/9/2010.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}